Alternatives to Morningstar for Indian Equity Research

If you are looking for an alternative to Morningstar for Indian equity research, judge each tool on the depth and accuracy of its Indian company data, whether it is point in time correct, and whether every number links back to the filing it came from. Those three tests, plus screening, filings coverage, forecasting support, and price, matter far more than any brand name.

Morningstar is best known globally for fund and equity data, independent research, and ratings, with especially strong mutual fund coverage. For an investor or professional focused on Indian listed companies, the practical question is not which brand is biggest, but which tool answers your specific research questions accurately, quickly, and with numbers you can trust and trace.

The categories of tools you are actually choosing between

Most tools that Indian investors and professionals reach for fall into three broad groups. Each solves a different problem, and the right choice depends on the work you do.

• Broad data terminals. Global platforms that cover many markets, asset classes, and news feeds. They are wide and deep on global coverage, and often carry significant cost and a learning curve.
• India-focused fundamental data and screening tools. Products built around Indian company financials, ratios, and screeners. They tend to be affordable and fast for filtering the market and scanning fundamentals.
• Newer AI-assisted research platforms. Tools that add natural-language search, summarisation, and drafting on top of company data, aiming to shorten the path from question to answer.

Rather than rank named products, it is more useful to define the criteria that separate a good fit from a poor one, then test any candidate against them yourself.

The criteria that actually matter

Here is a practical checklist you can apply to any platform, whether it is a global terminal, an Indian screener, or an AI-assisted tool.

Criterion	What to check	Why it matters
Data depth and accuracy	Are Indian company financials complete and correct across P&L, balance sheet, and cash flow?	Wrong or shallow data leads to wrong conclusions, however good the interface looks.
Point in time correctness	Can the tool show what was known on a past date, not just today’s restated view?	Backtests and historical comparisons break if later revisions leak into the past.
Source linkage	Does each number link back to the specific filing or statement it came from?	Traceable numbers can be verified and defended, which matters for professional work.
Filings and earnings coverage	Are annual and quarterly filings, XBRL, and earnings calls covered and searchable?	Primary documents are where the real signal lives, beyond summary ratios.
Screening	Can you filter the Indian universe on fundamentals, valuation, and custom logic?	Idea generation and universe narrowing depend on flexible, reliable screens.
Forecasting and modelling	Does the tool support projections, scenarios, or model building, and are assumptions visible?	Research often needs a forward view, and hidden assumptions are hard to trust.
Price and access	Is pricing transparent and matched to your use, from retail to professional?	The best tool is the one you can afford to use consistently, not just trial once.

You will rarely find one tool that scores highest on every row. The goal is to match the criteria to your workflow, then weigh honestly.

How to test data depth and accuracy

Do not take coverage claims at face value. Pick three or four Indian companies you already know well, ideally across sectors such as a bank, a cement or auto name, and a consumer company, and check the numbers against the actual filings.

Look for the boring failure modes: annual figures that do not reconcile to the four quarters, banks with missing or odd per-share data, or one-off items that quietly distort a trend. A platform that gets your familiar companies right is more likely to get unfamiliar ones right too.

A simple test: open a company you know cold, then see how fast you can trace a single reported number back to the exact statement it came from. If you cannot, that number is hard to trust and harder to defend.

Why point in time and source linkage are non-negotiable

Two criteria deserve special weight for Indian research, because they are easy to overlook and expensive to get wrong.

Point in time correctness means the tool can reconstruct what was actually known on a given date. Filings get revised, results get restated, and companies report late. If a platform silently overwrites history with the latest view, any backtest or historical comparison you run is quietly contaminated. For anyone studying how a company or signal behaved over time, this is the difference between a real result and an illusion.

Source linkage means every figure connects back to the primary document it was drawn from. When a number is traceable to a specific annual report, quarterly filing, or XBRL statement, you can verify it, cite it, and stand behind it. When it is not, you are trusting a black box. For professional work, and increasingly for serious individual investors, that traceability is what separates a research tool from a data feed.

Filings, earnings, and forecasting depth

Ratios and screens get you started, but the substance of research is in primary documents. Check whether a platform actually indexes annual and quarterly filings, XBRL data, and earnings call material, and whether you can search across them rather than reading one PDF at a time.

On forecasting, the useful question is not whether a tool produces a number, but whether it shows its work. Are the assumptions behind a projection visible and adjustable? Can you build or stress a model rather than accepting a single opaque output? A forecast you cannot inspect is hard to rely on, no matter how confident it looks.

This is one area where newer, India-specific research terminals have leaned in. Altys, for example, is a research terminal built specifically for Indian equities on point in time, source-linked data, and it is one option worth evaluating against the same checklist you would apply to any other tool. The right move is always to test it against your own companies and questions, not to take any description, including this one, on trust.

A note on cost and fit

Price is a real constraint, and the categories differ sharply here. Broad global terminals carry the most capability and typically the highest cost. India-focused screeners are usually the most affordable and are excellent for fast filtering. AI-assisted platforms sit across a range and are best judged on whether the assistance is grounded in accurate, traceable data rather than on the novelty of the interface.

Be wary of paying for global breadth you will never use if your work is entirely Indian equities, and equally wary of a cheap screener if your work demands point in time correctness and source-linked audit trails it was never built to provide. Match the spend to the depth your research actually requires.

How to choose

There is no single best alternative to Morningstar for Indian research, because the right answer depends on what you do. Work from the criteria, not the brand.

• If you need global breadth across markets and asset classes, a broad terminal is the natural home, and cost is the trade-off.
• If you mostly filter and scan Indian fundamentals, an affordable India-focused screener may cover you well.
• If your work depends on point in time correctness, source-linked numbers, and deep filings coverage, weight those rows heavily and test candidates hard against your own companies.

Run the same test on every tool you consider: pick a few Indian companies you know, check the numbers against the filings, try to trace one figure back to its source, and see whether the historical view is point in time honest. Whichever platform passes that test on the questions you care about is the right alternative for you.

This article is about research tools, not securities. It is educational and does not contain investment advice or stock recommendations. Altys Labs is not a registered Research Analyst or Investment Adviser.